The Practice of Retransplantation for Recurrent Alcohol-associated Liver Disease in the United States Is Uncommon With Acceptable Outcomes by Thomas G. Cotter, MD, MS, Matthew A. Odenwald, MD, PhD, Sarah R. Lieber, MD, MSCR, Nicole E. Rich, MD, Gene Im, MD, Michael Charlton, MD, Amit G. Singal, MD, Mack C. Mitchell, MD

Get full text

“Raising HOPE”: Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era by Thomas G. Cotter, MB BCh, Jennifer Wang, MD, Sarah R. Lieber, MD, Matthew A. Odenwald, MD, Nicole E. Rich, MD, Jorge A. Marrero, MD, Amit G. Singal, MD, Mack C. Mitchell, MD, Andrew Aronsohn, MD, Michael Charlton, MD, John Fung, MD

Get full text

Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma by Anjiya Shaikh, MBBS, Karthik Goli, BS, Nicole E. Rich, MD, Jihane N. Benhammou, MD, PhD, Saira Khaderi, MD, PhD, Ruben Hernaez, MD, PhD, Vatche G. Agopian, MD, John M. Vierling, MD, Donghee Kim, MD, PhD, Aijaz Ahmed, MD, John A. Goss, MD, Abbas Rana, MD, Fasiha Kanwal, MD, MSHS, George Cholankeril, MD, MSECR

Get full text